More evidence of the failure of oral cyclosporine to maintain remission due to intravenous cyclosporine in IBD.
Korelitz
B I
BI
D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D007262:Infusions, Intravenous; D012008:Recurrence; D017211:Treatment Failure
D007166:Immunosuppressive Agents; D016572:Cyclosporine